Clinical trial
A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe…
NCT02942004 · Supernus Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT02942004 |
|---|---|
| Title | A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B) |
| Official title | A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression |
| Lead sponsor | Supernus Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postpartum Depression |
| Intervention type | Drug |
| Interventions | Placebo, SAGE-547 60 μg/kg/h, SAGE-547 90 μg/kg/h |
| Enrollment | 138 |
| Start date | Aug 1, 2016 |
| Primary completion | Sep 24, 2017 |
| Completion | Oct 19, 2017 |
| First posted | Oct 21, 2016 |
| Last update posted | Oct 14, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: